Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

1.

Intravenous Preload of Mesenchymal Stem Cells Rescues Erectile Function in a Rat Model of Cavernous Nerve Injury.

Takayanagi A, Sasaki M, Kataoka-Sasaki Y, Kobayashi K, Matsuda Y, Oka S, Masumori N, Kocsis JD, Honmou O.

J Sex Med. 2015 Aug;12(8):1713-21. doi: 10.1111/jsm.12957. Epub 2015 Jul 24.

PMID:
26211660
2.

Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells.

Matsushita T, Lankford KL, Arroyo EJ, Sasaki M, Neyazi M, Radtke C, Kocsis JD.

Exp Neurol. 2015 May;267:152-64. doi: 10.1016/j.expneurol.2015.03.001. Epub 2015 Mar 12.

PMID:
25771801
3.

Olfactory-ensheathing cell transplantation for peripheral nerve repair: update on recent developments.

Radtke C, Kocsis JD.

Cells Tissues Organs. 2014;200(1):48-58. doi: 10.1159/000369006. Epub 2015 Mar 4.

PMID:
25765445
4.

Intravenous mesenchymal stem cell therapy after recurrent laryngeal nerve injury: a preliminary study.

Lerner MZ, Matsushita T, Lankford KL, Radtke C, Kocsis JD, Young NO.

Laryngoscope. 2014 Nov;124(11):2555-60. doi: 10.1002/lary.24798. Epub 2014 Jul 7.

PMID:
25043703
5.

Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration.

Matthes SM, Reimers K, Janssen I, Liebsch C, Kocsis JD, Vogt PM, Radtke C.

Biomed Res Int. 2013;2013:573169. doi: 10.1155/2013/573169. Epub 2013 Dec 26.

6.

Olfactory ensheathing cells, but not Schwann cells, proliferate and migrate extensively within moderately X-irradiated juvenile rat brain.

Lankford KL, Brown RJ, Sasaki M, Kocsis JD.

Glia. 2014 Jan;62(1):52-63. doi: 10.1002/glia.22583. Epub 2013 Oct 24.

PMID:
24166823
7.

Sural nerve defects after nerve biopsy or nerve transfer as a sensory regeneration model for peripheral nerve conduit implantation.

Radtke C, Kocsis JD, Reimers K, Allmeling C, Vogt PM.

Med Hypotheses. 2013 Sep;81(3):500-2. doi: 10.1016/j.mehy.2013.06.020. Epub 2013 Jul 16.

PMID:
23867139
8.

Sciatic nerve regeneration is not inhibited by anti-NGF antibody treatment in the adult rat.

Lankford KL, Arroyo EJ, Liu CN, Somps CJ, Zorbas MA, Shelton DL, Evans MG, Hurst SI, Kocsis JD.

Neuroscience. 2013 Jun 25;241:157-69. doi: 10.1016/j.neuroscience.2013.03.024. Epub 2013 Mar 24.

PMID:
23531437
9.

Paracrine loop of keratinocyte proliferation and directed neuritic outgrowth in a neuroepithelial coculture.

Radtke C, Rennekampff HO, Reimers K, Vogt PM, Kocsis JD.

Ann Plast Surg. 2013 Feb;70(2):162-7. doi: 10.1097/SPA.0b013e318276d946.

PMID:
23328123
10.

Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.

Suzuki J, Sasaki M, Harada K, Bando M, Kataoka Y, Onodera R, Mikami T, Wanibuchi M, Mikuni N, Kocsis JD, Honmou O.

Brain Res. 2013 Feb 25;1497:15-22. doi: 10.1016/j.brainres.2012.12.028. Epub 2012 Dec 27.

PMID:
23274536
11.

Peripheral nerve injuries and transplantation of olfactory ensheathing cells for axonal regeneration and remyelination: fact or fiction?

Radtke C, Kocsis JD.

Int J Mol Sci. 2012 Oct 10;13(10):12911-24. doi: 10.3390/ijms131012911. Review.

12.

Bone marrow stem cells in experimental stroke.

Kocsis JD, Honmou O.

Prog Brain Res. 2012;201:79-98. doi: 10.1016/B978-0-444-59544-7.00005-6. Review.

PMID:
23186711
13.

Mesenchymal stem cells: therapeutic outlook for stroke.

Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD.

Trends Mol Med. 2012 May;18(5):292-7. doi: 10.1016/j.molmed.2012.02.003. Epub 2012 Mar 27. Review.

PMID:
22459358
14.

CNPase expression in olfactory ensheathing cells.

Radtke C, Sasaki M, Lankford KL, Gallo V, Kocsis JD.

J Biomed Biotechnol. 2011;2011:608496. doi: 10.1155/2011/608496. Epub 2011 Nov 16.

15.

Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.

Sasaki M, Honmou O, Radtke C, Kocsis JD.

PLoS One. 2011;6(10):e26577. doi: 10.1371/journal.pone.0026577. Epub 2011 Oct 24.

16.

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S, Onodera R, Waxman SG, Kocsis JD.

Brain. 2011 Jun;134(Pt 6):1790-807. doi: 10.1093/brain/awr063. Epub 2011 Apr 14.

17.

Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments.

Sasaki M, Lankford KL, Radtke C, Honmou O, Kocsis JD.

Exp Neurol. 2011 May;229(1):88-98. doi: 10.1016/j.expneurol.2011.01.010. Epub 2011 Jan 28. Review.

PMID:
21281634
18.
19.

Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome.

Osaka M, Honmou O, Murakami T, Nonaka T, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jul 9;1343:226-35. doi: 10.1016/j.brainres.2010.05.011. Epub 2010 May 12.

PMID:
20470759
20.

Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD.

Brain Res. 2010 Jun 2;1334:84-92. doi: 10.1016/j.brainres.2010.04.006. Epub 2010 Apr 9.

PMID:
20382136
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk